Mersana Therapeutics, Inc. Research and Development Expense
Mersana Therapeutics, Inc. reported Research and Development Expense of $12.18 million for the 3-month period ending 2025-09-30, per its 10-Q filed 2025-11-14.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2025-11-14
- Mersana Therapeutics, Inc. research and development expense for the quarter ending 2025-09-30 was $12.18M, a 17.71% decline year-over-year.
- Mersana Therapeutics, Inc. research and development expense for the quarter ending 2025-06-30 was $16.22M, a 5.96% decline year-over-year.
- Mersana Therapeutics, Inc. research and development expense for the quarter ending 2025-03-31 was $18.34M, a 1.85% decline year-over-year.
- Mersana Therapeutics, Inc. research and development expense for the quarter ending 2024-12-31 was $22.29M, a 3.68% increase year-over-year.
- Mersana Therapeutics, Inc. research and development expense for fiscal 2024 was $73.02M, a 50.75% decline from fiscal 2023.
- Mersana Therapeutics, Inc. research and development expense for fiscal 2023 was $148.27M, a 14.49% decline from fiscal 2022.
- Mersana Therapeutics, Inc. research and development expense for fiscal 2022 was $173.38M, a 31.34% increase from fiscal 2021.
- Mersana Therapeutics, Inc. research and development expense for fiscal 2021 was $132.01M, a 96.93% increase from fiscal 2020.
| Period end | Research and Development Expense 3 month | Research and Development Expense 6 month | Research and Development Expense 9 month | Research and Development Expense 12 month |
|---|---|---|---|---|
| 2025-09-30 | $12.18M 10-Q · filed 2025-11-14 | $28.40M derived: sum of 2 quarters · filed 2025-11-14 | $46.74M 10-Q · filed 2025-11-14 | $69.03M derived: sum of 4 quarters · filed 2025-11-14 |
| 2025-06-30 | $16.22M 10-Q · filed 2025-08-13 | $34.56M 10-Q · filed 2025-08-13 | $56.84M derived: sum of 3 quarters · filed 2025-08-13 | $71.65M derived: sum of 4 quarters · filed 2025-11-14 |
| 2025-03-31 | $18.34M 10-Q · filed 2025-05-15 | $40.63M derived: sum of 2 quarters · filed 2025-05-15 | $55.43M derived: sum of 3 quarters · filed 2025-11-14 | $72.67M derived: sum of 4 quarters · filed 2025-11-14 |
| 2024-12-31 | $22.29M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $37.09M derived: sum of 2 quarters · filed 2025-11-14 | $54.33M derived: sum of 3 quarters · filed 2025-11-14 | $73.02M 10-K · filed 2025-03-03 |
| 2024-09-30 | $14.80M 10-Q · filed 2025-11-14 | $32.05M derived: sum of 2 quarters · filed 2025-11-14 | $50.73M 10-Q · filed 2025-11-14 | $72.23M derived: sum of 4 quarters · filed 2025-11-14 |
| 2024-06-30 | $17.25M 10-Q · filed 2025-08-13 | $35.93M 10-Q · filed 2025-08-13 | $57.43M derived: sum of 3 quarters · filed 2025-08-13 | $87.96M derived: sum of 4 quarters · filed 2025-08-13 |
| 2024-03-31 | $18.69M 10-Q · filed 2025-05-15 | $40.18M derived: sum of 2 quarters · filed 2025-05-15 | $70.71M derived: sum of 3 quarters · filed 2025-05-15 | $119.68M derived: sum of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | $21.50M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $52.03M derived: sum of 2 quarters · filed 2025-03-03 | $100.99M derived: sum of 3 quarters · filed 2025-03-03 | $148.27M 10-K · filed 2025-03-03 |
| 2023-09-30 | $30.53M 10-Q · filed 2024-11-13 | $79.50M derived: sum of 2 quarters · filed 2024-11-13 | $126.77M 10-Q · filed 2024-11-13 | $172.48M derived: sum of 4 quarters · filed 2025-03-03 |
| 2023-06-30 | $48.97M 10-Q · filed 2024-08-13 | $96.24M 10-Q · filed 2024-08-13 | $141.95M derived: sum of 3 quarters · filed 2025-03-03 | $192.59M derived: sum of 4 quarters · filed 2025-03-03 |
| 2023-03-31 | $47.27M 10-Q · filed 2024-05-09 | $92.98M derived: sum of 2 quarters · filed 2025-03-03 | $143.62M derived: sum of 3 quarters · filed 2025-03-03 | $184.85M derived: sum of 4 quarters · filed 2025-03-03 |
| 2022-12-31 | $45.71M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $96.35M derived: sum of 2 quarters · filed 2025-03-03 | $137.58M derived: sum of 3 quarters · filed 2025-03-03 | $173.38M 10-K · filed 2025-03-03 |
| 2022-09-30 | $50.64M 10-Q · filed 2023-11-07 | $91.87M derived: sum of 2 quarters · filed 2023-11-07 | $127.68M 10-Q · filed 2023-11-07 | $165.04M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | $41.23M 10-Q · filed 2023-08-08 | $77.04M 10-Q · filed 2023-08-08 | $114.41M derived: sum of 3 quarters · filed 2024-02-28 | $149.68M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | $35.81M 10-Q · filed 2023-05-09 | $73.17M derived: sum of 2 quarters · filed 2024-02-28 | $108.45M derived: sum of 3 quarters · filed 2024-02-28 | $140.40M derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | $37.37M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $72.64M derived: sum of 2 quarters · filed 2024-02-28 | $104.60M derived: sum of 3 quarters · filed 2024-02-28 | $132.01M 10-K · filed 2024-02-28 |
| 2021-09-30 | $35.27M 10-Q · filed 2022-11-07 | $67.23M derived: sum of 2 quarters · filed 2022-11-07 | $94.64M 10-Q · filed 2022-11-07 | $117.50M derived: sum of 4 quarters · filed 2022-11-07 |
| 2021-06-30 | $31.95M 10-Q · filed 2022-08-08 | $59.37M 10-Q · filed 2022-08-08 | $82.23M derived: sum of 3 quarters · filed 2022-08-08 | $98.77M derived: sum of 4 quarters · filed 2022-08-08 |
| 2021-03-31 | $27.41M 10-Q · filed 2022-05-09 | $50.27M derived: sum of 2 quarters · filed 2022-05-09 | $66.82M derived: sum of 3 quarters · filed 2022-05-09 | $82.23M derived: sum of 4 quarters · filed 2022-05-09 |
| 2020-12-31 | $22.86M 10-K · filed 2021-02-26 | $39.40M derived: sum of 2 quarters · filed 2021-11-09 | $54.82M derived: sum of 3 quarters · filed 2021-11-09 | $67.04M 10-K · filed 2023-02-28 |
| 2020-09-30 | $16.55M 10-Q · filed 2021-11-09 | $31.96M derived: sum of 2 quarters · filed 2021-11-09 | $44.18M 10-Q · filed 2021-11-09 | $56.61M derived: sum of 4 quarters · filed 2021-11-09 |
| 2020-06-30 | $15.41M 10-Q · filed 2021-08-06 | $27.63M 10-Q · filed 2021-08-06 | $40.06M derived: sum of 3 quarters · filed 2021-08-06 | $53.76M derived: sum of 4 quarters · filed 2021-08-06 |
| 2020-03-31 | $12.22M 10-Q · filed 2021-05-10 | $24.65M derived: sum of 2 quarters · filed 2021-05-10 | $38.35M derived: sum of 3 quarters · filed 2021-05-10 | $52.12M derived: sum of 4 quarters · filed 2021-05-10 |
| 2019-12-31 | $12.43M 10-K · filed 2021-02-26 | $26.13M derived: sum of 2 quarters · filed 2021-02-26 | $39.90M derived: sum of 3 quarters · filed 2021-02-26 | $55.04M 10-K · filed 2022-02-28 |
| 2019-09-30 | $13.70M 10-K · filed 2021-02-26 | $27.47M derived: sum of 2 quarters · filed 2021-02-26 | $42.61M 10-Q · filed 2020-11-09 | $62.43M derived: sum of 4 quarters · filed 2021-02-26 |
| 2019-06-30 | $13.77M 10-K · filed 2021-02-26 | $28.91M 10-Q · filed 2020-08-07 | $48.73M derived: sum of 3 quarters · filed 2021-02-26 | $63.91M derived: sum of 4 quarters · filed 2021-02-26 |
| 2019-03-31 | $15.14M 10-K · filed 2021-02-26 | $34.96M derived: sum of 2 quarters · filed 2021-02-26 | $50.14M derived: sum of 3 quarters · filed 2021-02-26 | $62.80M derived: sum of 4 quarters · filed 2021-02-26 |
| 2018-12-31 | $19.82M 10-K · filed 2020-02-28 | $35.00M derived: sum of 2 quarters · filed 2020-02-28 | $47.66M derived: sum of 3 quarters · filed 2020-02-28 | $59.91M 10-K · filed 2021-02-26 |
| 2018-09-30 | $15.18M 10-K · filed 2020-02-28 | $27.84M derived: sum of 2 quarters · filed 2020-02-28 | $40.10M 10-Q · filed 2019-11-06 | $54.65M derived: sum of 4 quarters · filed 2020-02-28 |
| 2018-06-30 | $12.66M 10-K · filed 2020-02-28 | $24.92M 10-Q · filed 2019-08-08 | $39.47M derived: sum of 3 quarters · filed 2020-02-28 | $50.89M derived: sum of 4 quarters · filed 2020-02-28 |
| 2018-03-31 | $12.26M 10-K · filed 2020-02-28 | $26.81M derived: sum of 2 quarters · filed 2020-02-28 | $38.22M derived: sum of 3 quarters · filed 2020-02-28 | $48.85M derived: sum of 4 quarters · filed 2020-02-28 |
| 2017-12-31 | $14.55M 10-K · filed 2019-03-08 | $25.97M derived: sum of 2 quarters · filed 2019-03-08 | $36.59M derived: sum of 3 quarters · filed 2019-03-08 | $46.70M 10-K · filed 2020-02-28 |
| 2017-09-30 | $11.41M 10-K · filed 2019-03-08 | $22.04M derived: sum of 2 quarters · filed 2019-03-08 | $32.15M 10-Q · filed 2018-11-13 | $40.99M derived: sum of 4 quarters · filed 2019-03-08 |
| 2017-06-30 | $10.63M 10-K · filed 2019-03-08 | $20.73M 10-Q · filed 2018-08-14 | $29.58M derived: sum of 3 quarters · filed 2019-03-08 | $37.13M derived: sum of 4 quarters · filed 2019-03-08 |
| 2017-03-31 | $10.11M 10-K · filed 2019-03-08 | $18.95M derived: sum of 2 quarters · filed 2019-03-08 | $26.51M derived: sum of 3 quarters · filed 2019-03-08 | $34.68M derived: sum of 4 quarters · filed 2019-03-08 |
| 2016-12-31 | $8.85M 10-K · filed 2018-03-28 | $16.40M derived: sum of 2 quarters · filed 2018-03-28 | $24.57M derived: sum of 3 quarters · filed 2018-03-28 | $32.01M 10-K · filed 2019-03-08 |
| 2016-09-30 | $7.55M 10-K · filed 2018-03-28 | $15.73M derived: sum of 2 quarters · filed 2018-03-28 | $23.16M 10-Q · filed 2017-11-13 | |
| 2016-06-30 | $8.17M 10-K · filed 2018-03-28 | $15.61M 10-Q · filed 2017-08-11 | ||
| 2016-03-31 | $7.44M 10-K · filed 2018-03-28 | |||
| 2015-12-31 | $21.35M 10-K · filed 2018-03-28 |